Improve results by narrowing your search by section [of LSE website] or theme. See the 'Narrow search by section' and 'Narrow search by theme' boxes [in right-hand column] after submitting your search query, and click relevant links [if present] to narrow your search.
search results for pharmaceutical policy
Pharmaceutical parallel trade: legal, policy, and...
13 May 2014:
Pharmaceutical parallel trade: legal, policy, and economic issues. Kanavos, Panos and Wouters, Olivier J. ( ... 2014). Pharmaceutical parallel trade: legal, policy, and economic issues. In: Culyer, Anthony, ( ed.) Encyclopedia of health economics.
LSE Health and Social Care - LSE Health and Social...
The research project, which will involve annual conferences and workshops in Beijing and London, will examine pharmaceutical policy and regulation in China. ... The project aims to provide policy-makers in China with an international comparative
Staff of the LSE Information Systems Department
26 Nov 2005:
Knowledge Production Vs Knowledge Management: The case of Pharmaceutical R&D”Proceedings of European Academy of Management 2002, Stockholm, Sweden. ... Mossialos).Information Infrastructure and Policy, Vol. 5, No. 3, 1996, pp 205-216.
EUROPP | European Politics and Policy
European Politics and Policy. Mar 7 2014. Posted in: Brussels Blog Round up.
LSE Review of Books
This work by LSE Review of Books is licensed under aVisit our sister blog: the LSE British Politics and Policy Blog. ... Visit our sister blog: the LSE European Politics and Policy Blog.
An overview of pharmaceutical policy in four...
The regulation of pharmaceutical markets is an important policy concern in many countries, and is generally undertaken with cost containment, efficiency, quality and equity objectives in mind. This article presents an overview of the demand-side and
EU pharmaceutical policy: the challenges and...
EU pharmaceutical policy: the challenges and opportunities of enlargement. Kanavos, Panos ( 2002). ... EU pharmaceutical policy: the challenges and opportunities of enlargement. Eurohealth, 8 ( 4).
The Japanese government's pharmaceutical policy...
The Japanese government's pharmaceutical policy and its effect on hospital financial viability. ... Oliver, Adam, Ikegami, N.and Ikeda, S. ( 1999). The Japanese government's pharmaceutical policy and its effect on hospital financial viability.
LSE Health - LSE Health - About us - LSE Health and...
Find outMajor research areas at LSE Health include Health Policy, with particular focus on comparative aspects, as well as theoretical and applied work in Health Economics. ... LSE Health is a WHO Collaborating Centre for Health Policy and
Constitutional asymmetry and pharmaceutical...
This paper offers a theoretical perspective on pharmaceutical policy-making in the European Union, and shows the lack of a single European market in medicines to be the result of a clash between the supranational free movement rules and national
1 2 3 4 5 6 7 8 9 10 [ Next 10 ]
Narrow search by section
Narrow search by theme